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Human T cell lymphotropic virus type I (HTLV-I) infec-
tion can lead to development of adult T cell leukemia/
lymphoma (ATL) or HTLV-I-associated myelopathy/
tropical spastic paraparesis (HAM/TSP) in a subset of
infected subjects. HTLV-I basic leucine zipper factor
(HBZ) gene has a critical role in HTLV-I infectivity and
the development of ATL and HAM/TSP. However, little is
known about immune response against HBZ in HTLV-I-
infected individuals. In this study, we examined antibody
responses against HBZ in serum/plasma samples from 436
subjects including HTLV-I seronegative donors, asympto-
matic carriers (AC), ATL, and HAM/TSP patients by the
luciferase immunoprecipitation system. The immunoreac-
tivity for HBZ was detected in subsets of all HTLV-I-
infected individuals but did not discriminate between AC,
ATL and HAM/TSP. However, the frequency of detection
of HBZ-specific antibodies in the serum of ATL patients
with the chronic subtype was higher than in ATL patients
with the lymphomatous subtype. Antibody responses
against HBZ were also detected in CSF of HAM/TSP
patients with anti-HBZ in serum. Antibody responses
against HBZ did not correlate with proviral load and HBZ
mRNA expression in HAM/TSP patients, but the presence
of HBZ-specific response was associated with reduced
CD4+ T cell activation in HAM/TSP patients. Moreover,
HBZ-specific antibody inhibited lymphoproliferation in
PBMC of HAM/TSP patients. This is the first report
demonstrating humoral immune response against HBZ
associated with HTLV-I infection. Thus, humoral immune
response against HBZ might play a role in HTLV-I
infection.
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